FMP

FMP

Blog
Screener
Extras

EFTR - eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatm

photo-url-https://financialmodelingprep.com/image-stock/EFTR.png

eFFECTOR Therapeutics, Inc.

EFTR

NASDAQ

11.62 USD

0.505 (4.35%)

About

ceo

Dr. Stephen T. Worland Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://effector.com

exchange

NASDAQ

Description

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is head...

CIK

0001828522

ISIN

US28202V2079

CUSIP

28202V108

Address

142 North Cedros Avenue

Phone

858 925 8215

Country

US

Employee

15

IPO Date

Mar 1, 2021

Summary

CIK

0001828522

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

28202V108

ISIN

US28202V2079

Country

US

Price

11.62

Beta

0.37

Volume Avg.

117.93k

Market Cap

39.7M

Shares

-

52-Week

8.45-37.0

DCF

-0.66

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.62

P/B

-

Website

https://effector.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest EFTR News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep